Identification of Desmoglein-2 as a novel target of Helicobacter pylori HtrA in epithelial cells.


Journal

Cell communication and signaling : CCS
ISSN: 1478-811X
Titre abrégé: Cell Commun Signal
Pays: England
ID NLM: 101170464

Informations de publication

Date de publication:
06 11 2021
Historique:
received: 09 09 2021
accepted: 14 09 2021
entrez: 7 11 2021
pubmed: 8 11 2021
medline: 25 2 2022
Statut: epublish

Résumé

High temperature requirement A (HtrA) is an active serine protease secreted by the group-I carcinogen Helicobacter pylori (H. pylori). The human cell adhesion protein and tumor suppressor E-cadherin (hCdh1) expressed on the surface of gastric epithelial cells was identified as the first HtrA substrate. HtrA-mediated hCdh1 cleavage and subsequent disruption of intercellular adhesions are considered as important steps in H. pylori pathogenesis. In this study, we performed a proteomic profiling of H. pylori HtrA (HpHtrA) to decipher the complex mechanism of H. pylori interference with the epithelial barrier integrity. Using a proteomic approach we identified human desmoglein-2 (hDsg2), neuropilin-1, ephrin-B2, and semaphorin-4D as novel extracellular HpHtrA substrates and confirmed the well characterized target hCdh1. HpHtrA-mediated hDsg2 cleavage was further analyzed by in vitro cleavage assays using recombinant proteins. In infection experiments, we demonstrated hDsg2 shedding from H. pylori-colonized MKN28 and NCI-N87 cells independently of pathogen-induced matrix-metalloproteases or ADAM10 and ADAM17. Characterizing the substrate specificity of HpHtrA revealed efficient hDsg2 cleavage underlining the importance of HpHtrA in opening intercellular junctions. Video Abstract.

Sections du résumé

BACKGROUND
High temperature requirement A (HtrA) is an active serine protease secreted by the group-I carcinogen Helicobacter pylori (H. pylori). The human cell adhesion protein and tumor suppressor E-cadherin (hCdh1) expressed on the surface of gastric epithelial cells was identified as the first HtrA substrate. HtrA-mediated hCdh1 cleavage and subsequent disruption of intercellular adhesions are considered as important steps in H. pylori pathogenesis. In this study, we performed a proteomic profiling of H. pylori HtrA (HpHtrA) to decipher the complex mechanism of H. pylori interference with the epithelial barrier integrity.
RESULTS
Using a proteomic approach we identified human desmoglein-2 (hDsg2), neuropilin-1, ephrin-B2, and semaphorin-4D as novel extracellular HpHtrA substrates and confirmed the well characterized target hCdh1. HpHtrA-mediated hDsg2 cleavage was further analyzed by in vitro cleavage assays using recombinant proteins. In infection experiments, we demonstrated hDsg2 shedding from H. pylori-colonized MKN28 and NCI-N87 cells independently of pathogen-induced matrix-metalloproteases or ADAM10 and ADAM17.
CONCLUSIONS
Characterizing the substrate specificity of HpHtrA revealed efficient hDsg2 cleavage underlining the importance of HpHtrA in opening intercellular junctions. Video Abstract.

Identifiants

pubmed: 34742300
doi: 10.1186/s12964-021-00788-x
pii: 10.1186/s12964-021-00788-x
pmc: PMC8571890
doi:

Substances chimiques

Bacterial Proteins 0
Desmoglein 2 0
EFNB2 protein, human 0
Ephrin-B2 0
Semaphorins 0
Neuropilin-1 144713-63-3
HtrA protein, H pylori EC 3.4.-
Serine Proteases EC 3.4.-
ADAM10 Protein EC 3.4.24.81
ADAM17 Protein EC 3.4.24.86

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108

Subventions

Organisme : Austrian Science Fund FWF
ID : P 31507
Pays : Austria

Informations de copyright

© 2021. The Author(s).

Références

J Invest Dermatol. 2012 Mar;132(3 Pt 2):776-84
pubmed: 22189787
Mol Cell Biol. 1994 Dec;14(12):8333-42
pubmed: 7526156
Gut Pathog. 2016 Jun 06;8:29
pubmed: 27274359
Gut Microbes. 2019;10(2):241-245
pubmed: 30183504
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
PLoS One. 2008;3(10):e3510
pubmed: 18946507
J Cell Sci. 2020 Mar 16;133(6):
pubmed: 32179593
Gastroenterology. 2003 Apr;124(4):983-92
pubmed: 12671895
J Immunol. 1997 Feb 15;158(4):1582-90
pubmed: 9029093
Mol Biol Cell. 2015 Sep 15;26(18):3165-77
pubmed: 26224314
Microbes Infect. 2015 Mar;17(3):205-14
pubmed: 25499189
Eur J Cancer. 2006 Sep;42(14):2397-403
pubmed: 16890424
Cell Microbiol. 2018 Jun;20(6):e12845
pubmed: 29582532
J Invest Dermatol. 2017 Feb;137(2):377-384
pubmed: 27765722
Helicobacter. 2018 Sep;23 Suppl 1:e12518
pubmed: 30203589
EMBO Rep. 2010 Oct;11(10):798-804
pubmed: 20814423
Cell Host Microbe. 2017 Oct 11;22(4):552-560.e5
pubmed: 29024645
Nat Med. 2011 Jan;17(1):96-104
pubmed: 21151137
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Sci Rep. 2019 Aug 13;9(1):11794
pubmed: 31409845
J Mol Biol. 2000 Jun 9;299(3):551-72
pubmed: 10835267
EMBO J. 2002 Apr 15;21(8):1948-56
pubmed: 11953314
J Cell Biochem. 1987 Jul;34(3):187-202
pubmed: 3611200
Cell. 1996 Feb 9;84(3):345-57
pubmed: 8608588
J Pathol. 2005 Oct;207(2):199-206
pubmed: 16025435
Cell. 2005 Dec 2;123(5):903-15
pubmed: 16325583
J Invest Dermatol. 2003 Aug;121(2):383-9
pubmed: 12880431
Gut. 2002 Oct;51(4):540-7
pubmed: 12235077
Toxins (Basel). 2017 Apr 11;9(4):
pubmed: 28398251
Nat Rev Mol Cell Biol. 2016 Sep;17(9):564-80
pubmed: 27353478
Oncogene. 1999 Nov 25;18(50):7080-90
pubmed: 10597309
J Basic Microbiol. 2013 May;53(5):402-9
pubmed: 22736569
Cell Adh Migr. 2007 Jan-Mar;1(1):28-32
pubmed: 19262094
J Invest Dermatol. 2007 Nov;127(11):2525-32
pubmed: 17934504
Int J Biochem Cell Biol. 2010 Jun;42(6):975-86
pubmed: 20188849
Sci Rep. 2020 Jun 29;10(1):10563
pubmed: 32601479
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Cell Host Microbe. 2007 Oct 11;2(4):209-11
pubmed: 18005737
Biochim Biophys Acta. 2008 Mar;1778(3):572-87
pubmed: 17854763
Infect Dis Clin North Am. 2010 Dec;24(4):853-69, vii
pubmed: 20937454
Physiol Rev. 2011 Apr;91(2):691-731
pubmed: 21527735
J Cell Sci. 2001 Jan;114(Pt 1):111-118
pubmed: 11112695
Acta Physiol (Oxf). 2021 Jan;231(1):e13492
pubmed: 32419327
Histochem Cell Biol. 2008 Jul;130(1):21-54
pubmed: 18386043
Sci Rep. 2016 Mar 17;6:23264
pubmed: 26983597
PLoS Pathog. 2021 Jan 29;17(1):e1009314
pubmed: 33513212
Trends Cell Biol. 2010 Dec;20(12):734-42
pubmed: 20817460
Exp Cell Res. 2009 Dec 10;315(20):3500-8
pubmed: 19665015
Mol Cell Proteomics. 2015 Aug;14(8):2213-28
pubmed: 26081835
Mol Cell Biol. 1995 Sep;15(9):4819-24
pubmed: 7651399
J Dermatol Sci. 2007 Jan;45(1):7-21
pubmed: 17141479

Auteurs

Sabine Bernegger (S)

Division of Microbiology, Department of Biosciences, Paris-Lodron University of Salzburg, Billroth Str. 11, 5020, Salzburg, Austria.

Robert Vidmar (R)

Department of Biochemistry and Molecular and Structural Biology, Jozef Stefan Institute, Jamova 39, 1000, Ljubljana, Slovenia.

Marko Fonovic (M)

Department of Biochemistry and Molecular and Structural Biology, Jozef Stefan Institute, Jamova 39, 1000, Ljubljana, Slovenia.

Gernot Posselt (G)

Division of Microbiology, Department of Biosciences, Paris-Lodron University of Salzburg, Billroth Str. 11, 5020, Salzburg, Austria.

Boris Turk (B)

Department of Biochemistry and Molecular and Structural Biology, Jozef Stefan Institute, Jamova 39, 1000, Ljubljana, Slovenia.

Silja Wessler (S)

Division of Microbiology, Department of Biosciences, Paris-Lodron University of Salzburg, Billroth Str. 11, 5020, Salzburg, Austria. Silja.Wessler@sbg.ac.at.
Cancer Cluster Salzburg and Allergy-Cancer-BioNano Research Centre, University of Salzburg, Billrothstrasse 11, 5020, Salzburg, Austria. Silja.Wessler@sbg.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH